AAAAAA
Results: 1-25/35
Authors:
MASON J
FREEMANTLE N
Citation: J. Mason et N. Freemantle, THE DILEMMA OF NEW DRUGS - ARE COSTS RISING FASTER THAN EFFECTIVENESS, PharmacoEconomics, 13(6), 1998, pp. 653-657
Authors:
ECCLES M
FREEMANTLE N
MASON J
Citation: M. Eccles et al., ASPIRIN PROPHYLAXIS FOR VASCULAR-DISEASE - REPLY, BMJ. British medical journal, 317(7168), 1998, pp. 1319-1319
Authors:
ECCLES M
CLARKE J
LIVINGSTONE M
FREEMANTLE N
MASON J
Citation: M. Eccles et al., NORTH OF ENGLAND EVIDENCE BASED GUIDELINES DEVELOPMENT PROJECT - GUIDELINE FOR THE PRIMARY-CARE MANAGEMENT OF DEMENTIA, BMJ. British medical journal, 317(7161), 1998, pp. 802-808
Authors:
ECCLES M
FREEMANTLE N
MASON J
Citation: M. Eccles et al., NORTH OF ENGLAND EVIDENCE BASED GUIDELINE DEVELOPMENT PROJECT - SUMMARY GUIDELINE FOR NONSTEROIDAL ANTIINFLAMMATORY DRUGS VERSUS BASIC ANALGESIA IN TREATING THE PAIN OF DEGENERATIVE ARTHRITIS, BMJ. British medical journal, 317(7157), 1998, pp. 526-530
Authors:
ECCLES M
FREEMANTLE N
MASON J
Citation: M. Eccles et al., NORTH OF ENGLAND EVIDENCE BASED DEVELOPMENT PROJECT - GUIDELINE FOR ANGIOTENSIN CONVERTING-ENZYME INHIBITORS IN PRIMARY-CARE MANAGEMENT OF ADULTS WITH SYMPTOMATIC HEART-FAILURE, BMJ. British medical journal, 316(7141), 1998, pp. 1369-1375
Authors:
ECCLES M
FREEMANTLE N
MASON J
Citation: M. Eccles et al., NORTH OF ENGLAND EVIDENCE BASED GUIDELINE DEVELOPMENT PROJECT - GUIDELINE ON THE USE OF ASPIRIN AS SECONDARY PROPHYLAXIS FOR VASCULAR-DISEASE IN PRIMARY-CARE, BMJ. British medical journal, 316(7140), 1998, pp. 1303-1309
Authors:
ECCLES M
FREEMANTLE N
MASON J
Citation: M. Eccles et al., NORTH OF ENGLAND EVIDENCE BASED GUIDELINES DEVELOPMENT PROJECT - METHODS OF DEVELOPING GUIDELINES FOR EFFICIENT DRUG-USE IN PRIMARY-CARE, BMJ. British medical journal, 316(7139), 1998, pp. 1232-1235
Authors:
FREEMANTLE N
MASON J
Citation: N. Freemantle et J. Mason, ASSUMPTIONS ARE METHODOLOGICALLY FLAWED, BMJ. British medical journal, 316(7139), 1998, pp. 1241-1242
Authors:
FREEMANTLE N
MASON JM
WATT I
Citation: N. Freemantle et al., EVIDENCE INTO PRACTICE - PRESCRIBING SELECTIVE SEROTONIN REUPTAKE INHIBITORS, International journal of technology assessment in health care, 14(2), 1998, pp. 387-391
Authors:
FREEMANTLE N
WOOD J
CRAWFORD F
Citation: N. Freemantle et al., EVIDENCE INTO PRACTICE, EXPERIMENTATION AND QUASI EXPERIMENTATION - ARE THE METHODS UP TO THE TASK, Journal of epidemiology and community health, 52(2), 1998, pp. 75-81
Authors:
FREEMANTLE N
MASON J
Citation: N. Freemantle et J. Mason, PUBLICATION BIAS IN CLINICAL-TRIALS AND ECONOMIC-ANALYSES, PharmacoEconomics, 12(1), 1997, pp. 10-16
Authors:
FREEMANTLE N
BARBOUR R
JOHNSON R
MARCHMENT M
KENNEDY A
Citation: N. Freemantle et al., THE USE OF STATINS - A CASE OF MISLEADING PRIORITIES, BMJ. British medical journal, 315(7112), 1997, pp. 826-828
Authors:
GRANADOS A
JONSSON E
BANTA HD
BERO L
BONAIR A
COCHET C
FREEMANTLE N
GRILLI R
GRIMSHAW J
HARVEY E
LEVI R
MARSHALL D
OXMAN A
PASART L
RAISANEN V
RIUS E
ESPINAS JA
Citation: A. Granados et al., EUR-ASSESS PROJECT SUBGROUP REPORT ON DISSEMINATION AND IMPACT, International journal of technology assessment in health care, 13(2), 1997, pp. 220-286
Authors:
FREEMANTLE N
DRUMMOND M
Citation: N. Freemantle et M. Drummond, BLINDING OF CLINICAL-TRIALS WITH CONCURRENT ECONOMIC-ANALYSIS - REPLY, JAMA, the journal of the American Medical Association, 277(21), 1997, pp. 1677-1677
Authors:
FREEMANTLE N
DRUMMOND M
Citation: N. Freemantle et M. Drummond, SHOULD CLINICAL-TRIALS WITH CONCURRENT ECONOMIC-ANALYSES BE BLINDED, JAMA, the journal of the American Medical Association, 277(1), 1997, pp. 63-64
Authors:
FREEMANTLE N
MASON JM
HAINES A
ECCLES MP
Citation: N. Freemantle et al., CONSORT - AN IMPORTANT STEP TOWARD EVIDENCE-BASED HEALTH-CARE, Annals of internal medicine, 126(1), 1997, pp. 81-83
Authors:
GILL PS
FREEMANTLE N
BERO L
HAAIJERRUSKAMP F
MARKELA M
BARJESTEH KP
Citation: Ps. Gill et al., GPS PRESCRIBING BEHAVIOR MAY BE AFFECTED BY DRUG PROMOTION, BMJ. British medical journal, 313(7053), 1996, pp. 367-367
Authors:
BLOOR K
MAYNARD A
FREEMANTLE N
Citation: K. Bloor et al., LESSONS FROM INTERNATIONAL EXPERIENCE IN CONTROLLING PHARMACEUTICAL EXPENDITURE .3. REGULATING INDUSTRY, BMJ. British medical journal, 313(7048), 1996, pp. 33-35
Authors:
BLOOR K
FREEMANTLE N
Citation: K. Bloor et N. Freemantle, LESSONS FROM INTERNATIONAL EXPERIENCE IN CONTROLLING PHARMACEUTICAL EXPENDITURE .2. INFLUENCING DOCTORS, BMJ. British medical journal, 312(7045), 1996, pp. 1525-1527
Authors:
FREEMANTLE N
Citation: N. Freemantle, ARE DECISIONS TAKEN BY HEALTH-CARE PROFESSIONALS RATIONAL - A NON SYSTEMATIC REVIEW OF EXPERIMENTAL AND QUASI-EXPERIMENTAL LITERATURE, Health policy, 38(2), 1996, pp. 71-81
Authors:
DEEKS J
WATT I
FREEMANTLE N
Citation: J. Deeks et al., ASPIRIN AND ACUTE MYOCARDIAL-INFARCTION - CLARIFYING THE MESSAGE, British journal of general practice, 45(397), 1995, pp. 395-396
Authors:
FREEMANTLE N
MASON J
Citation: N. Freemantle et J. Mason, METAANALYSIS OF ANTIDEPRESSANT PRESCRIBING - DROP-OUT RATES WERE PRESENTED IN A MISLEADING MANNER, BMJ. British medical journal, 311(7007), 1995, pp. 751-751
Authors:
HOUSE A
SHELDON T
FREEMANTLE N
Citation: A. House et al., ANTIDEPRESSANTS AND SUICIDE - STUDY IS BASED ON UNPROVED ASSUMPTIONS, BMJ. British medical journal, 311(6996), 1995, pp. 55-55
Authors:
FREEMANTLE N
HENRY D
MAYNARD A
TORRANCE G
Citation: N. Freemantle et al., PROMOTING COST-EFFECTIVE PRESCRIBING - BRITAIN LAGS BEHIND, BMJ. British medical journal, 310(6985), 1995, pp. 955-956
Authors:
FREEMANTLE N
Citation: N. Freemantle, DEALING WITH UNCERTAINTY - WILL SCIENCE SOLVE THE PROBLEMS OF RESOURCE-ALLOCATION IN THE UK NHS, Social science & medicine, 40(10), 1995, pp. 1365-1370